Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,957 | -1,528 | -20,729 | -15,470 | -10,960 |
| Depreciation Amortization | N/A | N/A | 64 | 48 | 47 |
| Other Working Capital | 68 | 45 | -5,972 | -6,120 | -6,609 |
| Other Operating Activity | 179 | 77 | 3,404 | 2,622 | 1,718 |
| Operating Cash Flow | $-2,710 | $-1,406 | $-23,233 | $-18,920 | $-15,804 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -15,443 | -12,951 | -10,957 |
| PPE Investments | -104 | -27 | -119 | -24 | -21 |
| Sale Of Investment | N/A | N/A | 33,989 | 25,989 | 17,989 |
| Investing Cash Flow | $-104 | $-27 | $18,427 | $13,014 | $7,011 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 2,985 | 2,937 | 84 |
| Financing Cash Flow | $N/A | $N/A | $2,985 | $2,937 | $84 |
| Exchange Rate Effect | N/A | N/A | 22 | 24 | 24 |
| Beginning Cash Position | 5,550 | 5,550 | 21,192 | 21,192 | 21,192 |
| End Cash Position | 2,737 | 4,117 | 19,393 | 18,247 | 12,507 |
| Net Cash Flow | $-2,814 | $-1,433 | $-1,799 | $-2,945 | $-8,685 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,710 | -1,406 | -23,233 | -18,920 | -15,804 |
| Capital Expenditure | -104 | -27 | -119 | -24 | -21 |
| Free Cash Flow | -2,813 | -1,433 | -23,352 | -18,944 | -15,825 |